PATENT CLAIM ANALYSIS

Application Number: 16029388
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-04
Patent Classification: ["514", "064000"]

Abstract:
Methods of treating or ameliorating a bacterial infection comprising administering a composition comprising a cyclic boronic acid ester Compound I in combination with meropenem are disclosed herewith. In some embodiments, the bacterial infection is a lower respiratory tract infection.

Claim (Index 48):
The method of  claim 44 , wherein meropenem is administered in a dose range from about 1.0 g to about 3.0 g.

Metadata:
- Claim Count in Document: 94.0
- Percentile: 95.0
- Lexical Diversity: 1.23529
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13843579', '14481496', '15935782', '15935862', '15015002']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7821349009530317
- 35 USC 102 Novelty (BERT): 0.539661760028284
- Combined Prediction Score: 0.7578875868605569
- Mean Citation Score: 315.957662
- Max Citation Score: 388.2348
- Similarity Product: 239.98016640572547

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test